Rostock, Germany

Tom Brunzel

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Symrise Ag. Active years: 2021-2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tom Brunzel: Innovator in Macrocyclic Ketone Synthesis

Introduction

Tom Brunzel is a notable inventor based in Rostock, Germany. He has made significant contributions to the field of chemistry, particularly in the synthesis of unsaturated macrocyclic ketones. With a total of 2 patents to his name, Brunzel's work is recognized for its innovative approaches and methodologies.

Latest Patents

Brunzel's latest patents include a method for preparing unsaturated macrocyclic ketones. This process involves several steps, including the preparation of macrocyclic dienes with a ring size of at least nine carbon atoms. The method also details the interaction of these starting materials with a palladium(II) salt or complex, an oxidant, a solvent, and optional components such as ligands, co-catalysts, and acids.

Career Highlights

Throughout his career, Tom Brunzel has been associated with Symrise AG, a leading global supplier of fragrances and flavorings. His work at Symrise AG has allowed him to explore and develop innovative chemical processes that enhance product offerings in the industry.

Collaborations

Brunzel has collaborated with several talented individuals, including Angela Köckritz and Diego A Jaime Trevino. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Tom Brunzel's contributions to the field of chemistry, particularly in the synthesis of unsaturated macrocyclic ketones, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…